Effect of some antimicrobial agents in malodorous prevention in dental implants

Effectiveness of different antimicrobial agents in malodorous prevention in the beginning of prosthetic phase of two-stage implants

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210705051795N1

Enrollment

Registered

2021-08-09

Start date

2021-08-06

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malodorous.

Interventions

Intervention 1: First group of intervention: In the exposure surgery session, before the healing abutments of participants are screwed, 2% Chlorhexidine gel (Morvabon brand

made in Morvabon Company in Iran) is added to the internal surface of implant fixtures applying with a sterile micro-brush. Intervention 2: Second group of intervention: In the exposure surgery sessio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Usage of 2-stage "snow" implant system Gingival depth of 2 to 3 mm

Exclusion criteria

Exclusion criteria: Uncontrolled systemic disease or history of specific medical condition Smoking habit or use of alcohol Current periodontal disease

Design outcomes

Primary

Measure	Time frame
The primary consequence variable is the "amount of Malodorous". Timepoint: Evaluation of Malodorous is performed 3 weeks after the intervention. Method of measurement: Evaluation is performed based on clinical observation or organoleptic method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Fathi

Esfahan University of Medical Sciences

amir_alty@yahoo.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026